medigraphic.com
ISSN 1561-3011 (Electronic)

2015, Number 3

<< Back

Rev Cubana Invest Bioméd 2015; 34 (3)

Progression of plasmacytoma of bone to multiple mieloma and a case report

Moreno RH, Villaseñor MJC, Vázquez MAB

Language: Spanish
References: 23
Page: 289-297
PDF size: 177.12 Kb.


ABSTRACT

Solitary plasmacytoma of bone and multiple myeloma are two monoclonal gammapathies that belong to the same group of neoplastic alterations of plasma cells. The plasmacytoma occasionally precedes myeloma. The sternal location of plasmocytoma is rare. This is the case of a man aged 75 years, with moderate pain in the dorsal region and short of breath when making medium efforts. The axial tomography showed osteolytic lesions in the lower third of sternum with radiological characteristics of a solitary plasmocytoma of bone in addition to lesions in the 5th left rib and scapulas. The bone marrow biopsy revealed 45% medullary plasmocytosis whereas immunoelectrophoresis showed Ig G concentration of 4210 mg/dl. Multiple myeloma was diagnosed and an analysis was made on the alterations leading to this result, with the purpose of bearing in mind the possibility of progression to a multiple myeloma in those patients with plasmocytoma of bone. The following case was presented in order to improve the quality of life of patients through timely diagnosis of plasmocytoma of bone and to avoid progression to multiple myeloma, thus achieving higher survival rates.


REFERENCES

  1. Ross S. AM Report: Surprising pathology. Part 2. Internal Medicine. 2011 May [cited 2009 Sep 29] Available from: http://boards.medscape.com/forums?128@664.XPfWaeyk7Jd@.29f67b9d!comment= 1&pa=14579269T1312682869064_13126828690641312682869068

  2. Bataille R, Chappard D, Marcelli C. Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma. J Clin Invest. 1991;88(1):62–6.

  3. Terpos E, Dimopoulos MA. Myeloma bone disease: pathophysiology and management. Ann Oncol. 2005;16(8):1223–31.

  4. Abe M, Hiura K, Wilde J. Osteoclasts enhance myeloma cell growth and survival via cell–cell contact: a vicious cycle between bone destruction and myeloma expansion. Blood. 2004;104(8):2484–91.

  5. Tanaka Y, Abe M, Hiasa M. Myeloma cell–osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin. Clin Cancer Res. 2007;13(3):816–23.

  6. Anthony S, Braunwald E, Kasper D, Hauser S, Longo D, Jameson J, et al. Plasma cell disorders. Harrison´s principles of internal medicine, 17 th edition. McGraw-Hill; 2009. p. 689-701.

  7. Kyle RA, Gertz MA, Witzig TE. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78(1):21–33.

  8. Fassas A, Tricot G. Results of high-dose treatment with autologous stem cell support in patients with multiple myeloma. Semin Hematol. 2001;38:231-42.

  9. Dimopoulos MA, Moulopoulos A, Delasalle K, Alexanian R. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Hematol Oncol Clin North Am. 1992;6:359-69.

  10. Bataille R, Sany J. Solitary myeloma: clinical and prognostic features of a review of 114 cases. Cancer. 1981;48:845-51.

  11. Dores GM, Landgren O, McGlynn KA, Curtis RE, Linet MS, Devesa SS. Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States. Br J Haematol. 2009;144:86-94.

  12. Rombolá C, León A, Muñoz S, Alix T. Plasmocitoma solitario de esternón: Presentación de un caso y revisión de la literatura. Oncología. 2006;29(9):378-81.

  13. Fernández P, Sancho M, Gras A, Talavera S. Plasmocitoma solitario de cabeza y cuello: Presentación de tres casos y revisión de la literatura. Acta Otorrinolaringol Esp. 2001;52:715-20.

  14. Olmo JA Del. Osteopatías hematológicas. In: Querol JR. Patología Ósea. Barcelona: Ed. Espaxs Publicaciones Médicas; 1983. p. 376-82.

  15. Conklin R, Alexanian R. Clinical classification of plasma cell myeloma. Arch Intern Med; 1975. p. 135-41.

  16. Burt M, Karpeh M, Ukoha O, Bains MS, McCormak PM, Rusch VW, et al. Medical tumors of the chest wall. Solitary plasmocytoma and Ewing’s sarcoma. J Thorac Cardiovasc Surg. 1993;105(1):89-96.

  17. Burt M, Zakowski M. Rare Primary Malignant Neoplasms. En: Pearson FG, editor. Thoracic Surgery. New York: Churchill Livingstone Inc. 1995; p. 807-26.

  18. Graeber GM, Jones DR, Pairolero PC. Primary Neoplasms. En: Pearson FG, editor. Thoracic Surgery. New York: Churchill Livingstone Inc. 1995; p.1237-1251.

  19. Bertanha F, Boufelli G, Pires O, Baptista A, Tadeu M, Regina C, et al. Oncologic progression of bone plasmacytomas to multiple myeloma. Clinics. 2006;61(2):139- 46.

  20. Holland J, Trenkner DA, Wasserman TH, Fineberg B. Plasmacytoma, treatment results and conversion to myeloma. Cancer. 1992;69:1513-7

  21. Quintero M, Rojas-Atencio A, Ruiz A, Gonzalez M, Herrera J, Atencio F, et al. Chromosome anomalies in Venezuelan patients with multiple mieloma. Invest Clin. 2003;44(4):327-35.

  22. Bataille R, Donadio D, Morlock G, Rosenberg F, Blotman F, Sany J, et al. Multiple myeloma of bones. Retrospective study of prognostic factors based on a series of 243 patients. Rev Rhum Mal Osteoartic. 1979;46:77-83.

  23. Bataille R, Morlock G, Rosenberg F, Lopitaux R, Blotman F, Sany J, et al. Value of successive chemotherapy in multiple myeloma of bone: Prospective study over 4 years. Rev Rhum Mal Osteoartic. 1980;47:77-82.




2020     |     www.medigraphic.com